Generic News: Breaking Generic News, Comments and Articles. - Page: 3

Mylan's Generic Version Of Tricor Tablets For Cholesterol Gets FDA Approval

CANONSBURG (dpa-AFX) - Generic drug maker Mylan Inc. (MYL), Friday said its unit Mylan Pharmaceuticals Inc. received final approval from the U.S. Food and Drug Administration for its Abbreviated N...

Forcing TRIPS on poorest countries threatens generics firms

Generics companies are likely to suffer if a plea from the world's poorest countries to be exempt from tough international intellectual property rights protection rules is ignored, warns Médecins Sans Frontières. Forcing least developed.....

Impax Laboratories Launches Authorized Generic of Zomig (zolmitriptan) Tablets and Orally Disintegrating Tablets in the U.S.

Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that its generics division, Global Pharmaceuticals, commenced shipment of authorized generic Zomig® (zolmitriptan) tablets and orally disintegrating tablets, 2.5 mg and 5 mg, in the U.S., as part of a Distribution, License, Development and Supply Agreement with AstraZeneca UK Limited (AstraZeneca)....

EU watchdog backs Bayer acne drug for certain patients

LONDON (Reuters) - Bayer's acne pill Diane 35 and its generic versions are safe to use in certain women when other options have failed, the European Medicines Agency said on Friday.

News and press releases: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 13-16 May 2013

European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) has concluded that the benefits of Diane 35 (cyproterone acetate 2 mg, ethinylestradiol 35 micrograms) and its generics outweigh the risks in a specific patient group, p...

News and press releases: Benefits of Diane 35 and generics outweigh risks in specific patient group

The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) has concluded that the benefits of Diane 35 (cyproterone acetate 2 mg, ethinylestradiol 35 micrograms) and its generics outweigh the risks, provided that several mea...

Mylan Launches Generic Tricor Tablets

PITTSBURGH, May 17, 2013 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has shipped Fenofibrate Tablets, 48 mg and 145 mg. Mylan Pharmaceut...

Acura Pharmaceuticals Is Grossly Undervalued And Poised For Rapid Growth

By StockPro2X:Acura Pharmaceuticals, Inc. (ACUR) is very undervalued at its current price per share in the lower 2's and has a very bright future. I began formulating this article prior to the announcement by the FDA that they were pulling commonly abused generic drugs such as generic OxyContin off the market; it was basically a gift to Acura cornering that multibillion-dollar market for abuse res...

Acorda Therapeutics’ Legal Department Recognized on Best Legal Departments List by Corporate Counsel Magazine

Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that the Company’s Legal department has been selected by Corporate Counsel magazine as one of the four “Best Legal Departments 2013.” “We are delighted by this honor,” said Jane Wasman, Acorda’s President, International and General Counsel. “As a department, we aim to creativel...

EMA: Benefits Outweigh VTE Risks With Hormone Drugs for Acne

The EMA has issued a recommendation that the benefits of the hormonal acne treatment Diane and its generics outweigh the risks, provided that several measures are taken to minimize the risk of thromboembolism. International Approvals

Sanofi fined for discouraging generic clopidogrel prescriptions

On 14 May 2013, French drugmaker sanofi-aventis was fined Euros 40.6 million by the French competition authority (L’Autorité de la concurrence) for marketing practices that discouraged sales of generic versions of its blood thinner Plavix (clopido...

Edison Investment - Neovacs - Moving forward in rheumatoid arthritis

Neovacs intends to initiate a Phase IIb trial with its lead product TNFα-Kinoid in rheumatoid arthritis (RA). The strategy is designed to maintain momentum of the programme while it seeks a partner. The Kinoid approach has potentially significant commercial advantages versus existing anti-TNF products in this large, but highly competitive therapeutic area. The ability to partner this drug,...

Actavis in discussions to buy Warner Chilcott

US generics maker Actavis (formerly Watson) confirmed on 14 May 2013 that the company had entered into discussions to buy Irish drugmaker Warner Chilcott.

FDA rejects Endo petition to stop Opana ER generics

On 10 May 2013, FDA announced that it had rejected a petition by Endo Pharmaceuticals (Endo) to stop generics of its powerful painkiller, Opana ER (oxymorphone).

The biggest drug patent losses for 2013

During 2012–2018 over US$290 billion of sales are at risk from patent expirations.  In fact, in 2013 alone patents will expire on drugs with yearly sales of US$29 billion. Generics are expected to grab 70% of those sales.

A Little Ranbaxy Example

Compare and contrast. Here we have Krishnan Ramalingam, from Ranbaxy's Corporate Communications department, in 2006: Being a global pharmaceutical major, Ranbaxy took a deliberate decision to pool its resources to fight neglected disease segments. ....

Generic atorvastatin brings £350m in savings

Generic versions of atorvastatin, which was previously only available from Pfizer as Lipitor, have saved the NHS more than £350m in 12 months, according to figures from the British Generic Manufacturers Association. The drug became available as a...

New PID Temperature Controllers Announced by Oven Industries Inc.

Oven Industries offers three new types of PID temperature controllers: AC load control, DC load control and AC/DC custom solutions. Mechanicsburg, PA (PRWEB) May 16, 2013 Oven Industries, Inc. has been an industry leader in pid temperature controllers and temperature sensors since 1964. Expertly designed, the proportional-integral-derivative PID temperature controllers are widely used in industr...

Regulatory Harmonization Institute Launches Workshops for Algerian Ministry of Health, Programs for Emerging Markets: Forums Address Drug/Medical Device Regulatory Requirements

Newly created Algerian Agence Nationale des Products Pharmaceutiques leads drug registration and approval of pharmaceuticals, issues visas to import pharmaceutical products and medical devices for use in human medicine The Regulatory Harmonization Institute, Inc. (RHI), an international, not-for-profit association dedicated to global harmonizati...

Novartis says has no intention of buying Actavis

ZURICH (Reuters) - Novartis has no plans to bid for U.S.-based generic drugmaker Actavis, which is the subject of intense takeover speculation, a spokesman for the Swiss drugmaker said on Thursday.

Ranbaxy: Looking Under the Rock

Here's an excellent, detailed look from Fortune at how things went off the rails at Ranbaxy and their generic atorvastatin (Lipitor). The company has been hit by a huge fine, and no wonder. This will give you the idea: On May 13, Ranbaxy pleaded gui...

Better together: Taiwan firms bridge mainland oncology market

Strong growth in China's generic oncology drug sector, along with government efforts to include such products in the national essential drugs list, is continuing to attract new entrants. Two Taiwan-based firms are now joining forces to venture across...

AmerisourceBergen Elects Lon R. Greenberg to Its Board of Directors

AmerisourceBergen Corporation (NYSE: ABC) today announced that Lon R. Greenberg, 62, has been elected to its Board of Directors, effective immediately. Mr. Greenberg fills the vacancy created by Charles H. Cotros’s retirement from the Board in February 2013. Mr. Greenberg also joined the Audit and Corporate Responsibility Committee and Finance Committee...

Andain Inc. Discusses and Provides Update on Its Breakthrough Wrinkle Treating Nano-Particles Booster and Delivery for Regenerating Skin Tissue

ARAD, Israel, May 16, 2013 /PRNewswire/ -- Andain Inc. (OTCBB: ANDN) ("Andain" or the "Company"), a company engaged in commercializing novel technologies in biotech, medical and life sciences fields through its incubator program, today discussed and provided an update on its breakthrough, innovative peptide booster and delivery nano-particles for wrinkle treating and regenerating skin tissue coll...

Hikma expects revenue to rise 13 pct in 2013

May 16 (Reuters) - Hikma Pharmaceuticals Plc raised its full-year revenue forecast, saying its generic antibiotic doxycycline was generating revenue ahead of its expectations.